Literature DB >> 3371576

Abnormalities in plasmas concentrations of lipoproteins and fibrinogen in type 1 (insulin-dependent) diabetic patients with increased urinary albumin excretion.

T Jensen1, S Stender, T Deckert.   

Abstract

Type 1 (insulin-dependent) diabetic patients with clinical nephropathy have a more than ten-fold increase in mortality of cardiovascular diseases compared with diabetic patients without nephropathy. The risk factors for cardiovascular disease, plasma concentrations of lipoproteins and fibrinogen, were investigated in 74 long-term diabetic patients: 37 with normal urinary albumin excretion, 20 with incipient nephropathy and 17 with overt clinical nephropathy based on urinary albumin excretion. The groups were matched according to sex, age and diabetes duration. The concentration of plasma cholesterol, very low density lipoprotein cholesterol, low density lipoprotein cholesterol, triglyceride and fibrinogen rose with increasing urinary albumin excretion. The plasma concentrations of these lipoproteins and fibrinogen were 11-14% higher in the patients with incipient nephropathy and 26-87% higher in the patients with overt clinical nephropathy compared with the patients without nephropathy. The plasma concentration of high density lipoprotein cholesterol was unaffected by albuminuria. Patients with normal urinary albumin excretion and HbA1c greater than 8.0% had significantly higher very low density lipoprotein- and lower high density lipoprotein cholesterol concentrations compared with patients with HbA1c less than 8.0%. Simple addition of the described risk factors can only account for a minor part of the greatly increased cardiovascular mortality in patients with diabetic nephropathy. An additional and possibly more decisive factor might be a change in the arterial wall, a change which promotes lipid accumulation and/or facilitates thrombus formation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3371576     DOI: 10.1007/bf00276846

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  27 in total

1.  Serum lipoproteins and cholesterol levels in normal subjects and in young patients with diabetes in relation to vascular complications.

Authors:  N R KEIDING; G V MANN; H F ROOT; E Y LAWRY; A MARBLE
Journal:  Diabetes       Date:  1952 Nov-Dec       Impact factor: 9.461

2.  Creatinine assay by a reaction-kinetic principle.

Authors:  K Larsen
Journal:  Clin Chim Acta       Date:  1972-10       Impact factor: 3.786

3.  Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study.

Authors:  T W Meade; S Mellows; M Brozovic; G J Miller; R R Chakrabarti; W R North; A P Haines; Y Stirling; J D Imeson; S G Thompson
Journal:  Lancet       Date:  1986-09-06       Impact factor: 79.321

4.  The effect of improved diabetic control on plasma lipid and lipoprotein levels: a comparison of conventional therapy and continuous subcutaneous insulin infusion.

Authors:  A Pietri; F L Dunn; P Raskin
Journal:  Diabetes       Date:  1980-12       Impact factor: 9.461

5.  The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus.

Authors:  K Borch-Johnsen; P K Andersen; T Deckert
Journal:  Diabetologia       Date:  1985-08       Impact factor: 10.122

6.  Plasma lipids and microangiopathy in insulin-dependent diabetes mellitus.

Authors:  R H Eckel; E McLean; J J Albers; M C Cheung; E L Bierman
Journal:  Diabetes Care       Date:  1981 Jul-Aug       Impact factor: 19.112

7.  Cigarette smoking and prevalence of microangiopathy in juvenile-onset insulin-dependent diabetes mellitus.

Authors:  J S Christiansen
Journal:  Diabetes Care       Date:  1978 May-Jun       Impact factor: 19.112

8.  Hypertension in diabetes as related to nephropathy. Early blood pressure changes.

Authors:  B Feldt-Rasmussen; K Borch-Johnsen; E R Mathiesen
Journal:  Hypertension       Date:  1985 Nov-Dec       Impact factor: 10.190

9.  Hyperlipidaemia in untreated nephrotic syndrome, increased production or decreased removal?

Authors:  M K Chan; J W Persaud; L Ramdial; Z Varghese; P Sweny; J F Moorhead
Journal:  Clin Chim Acta       Date:  1981-12-24       Impact factor: 3.786

View more
  36 in total

1.  [Cardiovascular risk factors in diabetic nephropathy].

Authors:  J Zimmermann; L Schramm; E Mulzer; E Heidbreder; H A Henrich; C Wanner
Journal:  Med Klin (Munich)       Date:  1997-02-15

Review 2.  Lipids and diabetic nephropathy.

Authors:  Rey F Rosario; Sharma Prabhakar
Journal:  Curr Diab Rep       Date:  2006-12       Impact factor: 4.810

Review 3.  Mechanisms of diabetic renal and cardiovascular disease.

Authors:  G C Viberti
Journal:  Acta Diabetol Lat       Date:  1990 Jul-Sep

Review 4.  Coronary heart disease in diabetes mellitus--antecedents and associations.

Authors:  P H Winocour
Journal:  Postgrad Med J       Date:  1991-10       Impact factor: 2.401

5.  [Lipoproteins and diabetic nephropathy].

Authors:  T Bertsch; J Aufenanger
Journal:  Med Klin (Munich)       Date:  1998-01-15

6.  Increased cholesterylester transfer activity in complicated type 1 (insulin-dependent) diabetes mellitus--its relationship with serum lipids.

Authors:  R P Dullaart; J E Groener; L D Dikkeschei; D W Erkelens; H Doorenbos
Journal:  Diabetologia       Date:  1989-01       Impact factor: 10.122

7.  Long-term effects of linoleic-acid-enriched diet on albuminuria and lipid levels in type 1 (insulin-dependent) diabetic patients with elevated urinary albumin excretion.

Authors:  R P Dullaart; B J Beusekamp; S Meijer; K Hoogenberg; J J van Doormaal; W J Sluiter
Journal:  Diabetologia       Date:  1992-02       Impact factor: 10.122

Review 8.  Albuminuria reflects widespread vascular damage. The Steno hypothesis.

Authors:  T Deckert; B Feldt-Rasmussen; K Borch-Johnsen; T Jensen; A Kofoed-Enevoldsen
Journal:  Diabetologia       Date:  1989-04       Impact factor: 10.122

9.  Microalbuminuria predicts the development of serum lipoprotein abnormalities favouring atherogenesis in newly diagnosed type 2 (non-insulin-dependent) diabetic patients.

Authors:  L Niskanen; M Uusitupa; H Sarlund; O Siitonen; E Voutilainen; I Penttilä; K Pyörälä
Journal:  Diabetologia       Date:  1990-04       Impact factor: 10.122

10.  Protective effect of Cassia glauca Linn. on the serum glucose and hepatic enzymes level in streptozotocin induced NIDDM in rats.

Authors:  Mamta Farswan; Papiya Mitra Mazumder; V Percha
Journal:  Indian J Pharmacol       Date:  2009-02       Impact factor: 1.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.